あすか製薬ホールディングスの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2023/02/27 | 1,150 | 1,154 | 1,143 | 1,144 | -10 | -0.9% | 38,100 |
2023/02/24 | 1,168 | 1,168 | 1,151 | 1,154 | -14 | -1.2% | 41,400 |
2023/02/22 | 1,175 | 1,178 | 1,168 | 1,168 | -11 | -0.9% | 35,500 |
2023/02/21 | 1,176 | 1,184 | 1,174 | 1,179 | -4 | -0.3% | 25,200 |
2023/02/20 | 1,173 | 1,190 | 1,169 | 1,183 | +18 | +1.5% | 24,600 |
2023/02/17 | 1,167 | 1,171 | 1,161 | 1,165 | -15 | -1.3% | 54,100 |
2023/02/16 | 1,190 | 1,193 | 1,178 | 1,180 | -1 | -0.1% | 35,300 |
2023/02/15 | 1,189 | 1,196 | 1,177 | 1,181 | -8 | -0.7% | 23,800 |
2023/02/14 | 1,196 | 1,196 | 1,180 | 1,189 | +6 | +0.5% | 38,000 |
2023/02/13 | 1,170 | 1,187 | 1,164 | 1,183 | +5 | +0.4% | 43,500 |
2023/02/10 | 1,189 | 1,193 | 1,176 | 1,178 | -25 | -2.1% | 50,000 |
2023/02/09 | 1,180 | 1,205 | 1,174 | 1,203 | +20 | +1.7% | 43,500 |
2023/02/08 | 1,195 | 1,201 | 1,180 | 1,183 | -13 | -1.1% | 48,900 |
2023/02/07 | 1,224 | 1,224 | 1,188 | 1,196 | -42 | -3.4% | 124,200 |
2023/02/06 | 1,220 | 1,240 | 1,218 | 1,238 | +22 | +1.8% | 56,300 |
2023/02/03 | 1,221 | 1,227 | 1,209 | 1,216 | -11 | -0.9% | 49,000 |
2023/02/02 | 1,232 | 1,233 | 1,222 | 1,227 | -12 | -1% | 33,200 |
2023/02/01 | 1,247 | 1,249 | 1,229 | 1,239 | -7 | -0.6% | 33,500 |
2023/01/31 | 1,247 | 1,255 | 1,238 | 1,246 | -1 | -0.1% | 42,600 |
2023/01/30 | 1,264 | 1,268 | 1,246 | 1,247 | -14 | -1.1% | 59,900 |
2023/01/27 | 1,269 | 1,272 | 1,261 | 1,261 | -14 | -1.1% | 22,500 |
2023/01/26 | 1,280 | 1,281 | 1,261 | 1,275 | -6 | -0.5% | 32,100 |
2023/01/25 | 1,265 | 1,287 | 1,260 | 1,281 | +6 | +0.5% | 32,900 |
2023/01/24 | 1,265 | 1,281 | 1,254 | 1,275 | +11 | +0.9% | 47,500 |
2023/01/23 | 1,241 | 1,264 | 1,237 | 1,264 | +23 | +1.9% | 40,300 |
2023/01/20 | 1,231 | 1,252 | 1,227 | 1,241 | +10 | +0.8% | 31,000 |
2023/01/19 | 1,243 | 1,250 | 1,226 | 1,231 | -12 | -1% | 46,800 |
2023/01/18 | 1,265 | 1,265 | 1,225 | 1,243 | -27 | -2.1% | 76,200 |
2023/01/17 | 1,253 | 1,275 | 1,240 | 1,270 | +17 | +1.4% | 42,300 |
2023/01/16 | 1,250 | 1,265 | 1,233 | 1,253 | -1 | -0.1% | 30,400 |
2023/01/13 | 1,274 | 1,286 | 1,253 | 1,254 | -35 | -2.7% | 57,100 |
2023/01/12 | 1,295 | 1,295 | 1,280 | 1,289 | +1 | +0.1% | 23,900 |
2023/01/11 | 1,274 | 1,299 | 1,274 | 1,288 | +22 | +1.7% | 34,000 |
2023/01/10 | 1,261 | 1,296 | 1,261 | 1,266 | -2 | -0.2% | 45,600 |
2023/01/06 | 1,236 | 1,274 | 1,236 | 1,268 | +36 | +2.9% | 38,600 |
2023/01/05 | 1,250 | 1,260 | 1,208 | 1,232 | -13 | -1% | 88,300 |
2023/01/04 | 1,291 | 1,291 | 1,244 | 1,245 | -52 | -4% | 46,600 |
2022/12/30 | 1,298 | 1,311 | 1,289 | 1,297 | +4 | +0.3% | 49,000 |
2022/12/29 | 1,264 | 1,299 | 1,264 | 1,293 | +22 | +1.7% | 50,700 |
2022/12/28 | 1,265 | 1,293 | 1,260 | 1,271 | -5 | -0.4% | 74,900 |
2022/12/27 | 1,275 | 1,282 | 1,259 | 1,276 | +1 | +0.1% | 31,300 |
2022/12/26 | 1,290 | 1,296 | 1,272 | 1,275 | +3 | +0.2% | 26,100 |
2022/12/23 | 1,270 | 1,284 | 1,263 | 1,272 | -3 | -0.2% | 50,100 |
2022/12/22 | 1,260 | 1,277 | 1,257 | 1,275 | +27 | +2.2% | 40,900 |
2022/12/21 | 1,241 | 1,260 | 1,234 | 1,248 | +8 | +0.6% | 47,200 |
2022/12/20 | 1,273 | 1,280 | 1,231 | 1,240 | -27 | -2.1% | 72,700 |
2022/12/19 | 1,263 | 1,278 | 1,260 | 1,267 | +4 | +0.3% | 49,800 |
2022/12/16 | 1,258 | 1,278 | 1,258 | 1,263 | +4 | +0.3% | 73,200 |
2022/12/15 | 1,258 | 1,270 | 1,251 | 1,259 | -8 | -0.6% | 41,500 |
2022/12/14 | 1,258 | 1,288 | 1,255 | 1,267 | +24 | +1.9% | 129,600 |
301~
350
件表示中 / 766件
類似銘柄と比較する
現在ご覧いただいている「あすかHD」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
あすかHD | 228,400円 | +0.3% | +2.7% | 2.19% | 12.94倍 | 1.04倍 |
|
武田と親密。婦人科領域に強い。先発品比率引き上げに注力。21年春にあすか製薬が持株会社化 |
栄研化 | 214,600円 | +7.6% | +57.5% | 2.47% | 16.57倍 | 1.63倍 |
|
臨床検査薬大手。便潜血検査試薬(FIT)はシェア7割弱。尿検査(ウロ)、遺伝子検査も育成 |
JCRファーマ | 63,600円 | -3.7% | -36.7% | 3.14% | 21.45倍 | 1.43倍 |
|
ヒト成長ホルモン製剤が主力、バイオ後続品も成長。希少疾病のバイオ新薬開発にも取り組む |
生化学 | 78,400円 | +10.5% | +169.1% | 3.83% | 12.40倍 | 0.59倍 |
|
複合糖質で独自性。開発は関節疾患関連に特化。2種のヒアルロン酸製剤は科研と参天が販売 |
富士製薬 | 151,800円 | +12.7% | +1.8% | 2.80% | 5.97倍 | 0.84倍 |
|
女性医療、急性期医療の2領域に強い後発薬メーカー。注射剤が主体。新薬・バイオ後続品も |
市場注目の銘柄
チャート関連のコラム